article thumbnail

FDA Finalizes Its Informed Consent Guidance for IRBs, Clinical Investigators and Sponsors

Hall Render

Food and Drug Administration (“FDA”) finalized “ Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors ” (“Final Guidance”), following the FDA’s earlier issuance of draft guidance on the subject in July 2014. study sponsor, regulatory agencies, etc.) On August 15, 2023, the U.S.

article thumbnail

FDA Guidance Provides Relief for MDR Reporting During a Pandemic

Exeed Regulatory Compliance

Timely MDR reporting is a challenging regulatory requirement for the industry. A new FDA guidance provides much-needed relief during a pandemic. Adverse event reporting requirements are very stringent, and late reporting of such events is a routine focus of FDA inspections and subsequent warning letters.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Guidance for Face Masks During Covid-19 Pandemic

Exeed Regulatory Compliance

Let us understand how they help and how FDA plans to regulate them. In this article, we explain the FDA requirements, and guidance for face masks when they are used for a medical purpose such as diagnosis, or cure, mitigation, treatment of prevention of disease.

article thumbnail

FDA Guidance for Face Shields and Respirators During the Covid-19 Pandemic

Exeed Regulatory Compliance

The FDA is consistently updating its Guidance and policy for various Face Masks, Face Shields and Respirators as new information becomes available. We recently discussed the FDA’s policy for Face Masks during COVID-19. In this article, we will cover Face Shields and Respirators. References FDA (2020, May).

article thumbnail

FDA Unlocks the Key to Innovation in Interoperable Medical Devices

Exeed Regulatory Compliance

Regulatory Breakthrough In a small step towards achieving the vision of interoperable medical devices, the FDA has recently authorized marketing of a novel software medical device using the De Novo Classification. the FDA expects for interoperable devices.

FDA 52
article thumbnail

Part 2: Who Regulates Healthcare AI?

AIHC

Artificial Intelligence & Regulatory Compliance Written by Joanne Byron , BS, LPN, CCA, CHA, CHCO, CHBS, CHCM, CIFHA, CMDP, COCAS, CORCM, OHCC, ICDCT-CM/PCS This article follows Part 1 - Basics of Artificial Intelligence (AI) and Healthcare Compliance published by AIHC on June 6, 2023. So, Who Regulates Healthcare AI?

FDA 45
article thumbnail

RFID in Healthcare: Navigating Security & Privacy Regulations

Healthcare IT Today

The following is a guest article by Peter Bloch, Market Development Manager – Healthcare at Avery Dennison Radio Frequency Identification (RFID) technology is revolutionizing healthcare, by improving efficiency, patient safety, and supply chain management. FDA’s Drug Supply Chain Security Act (DSCSA).

HIPAA 92